{"version":"1.0","type":"link","title":"Ebastine targets HER2/HER3 signaling and cancer stem cell traits to overcome trastuzumab resistance in HER2‑positive breast cancer.","author_name":"Jung E 외","author_url":"https://prs-insight.online/author/Jung%20E","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/78664","thumbnail_width":1200,"thumbnail_height":630}